Network-based approaches in drug discovery and early development
about
Constellation pharmacology: a new paradigm for drug discoveryDiversity-oriented synthetic strategies applied to cancer chemical biology and drug discoveryDrug repositioning approaches for the discovery of new therapeutics for Alzheimer's diseaseCombination therapeutics in complex diseasesLigand-target prediction by structural network biology using nAnnoLyzeA Multilayer Network Approach for Guiding Drug Repositioning in Neglected DiseasesPhIN: A Protein Pharmacology Interaction Network DatabaseToward an integrated software platform for systems pharmacologySaffron'omics': The challenges of integrating omic technologiesProcess Pharmacology: A Pharmacological Data Science Approach to Drug Development and TherapyNetwork representations of immune system complexity.A curated C. difficile strain 630 metabolic network: prediction of essential targets and inhibitors.Logic-Based and Cellular Pharmacodynamic Modeling of Bortezomib Responses in U266 Human Myeloma Cells.Functional Analysis and Characterization of Differential Coexpression Networks.Translational intracerebral hemorrhage: a need for transparent descriptions of fresh tissue sampling and preclinical model qualityA Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine.Toward a systems-level view of dynamic phosphorylation networksNovel Holistic Approaches for Overcoming Therapy Resistance in Pancreatic and Colon Cancers.Network-based Approaches in Pharmacology.Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.A protein network descriptor server and its use in studying protein, disease, metabolic and drug targeted networks.Biological network border detection.Boolean network modeling in systems pharmacology.Web-based drug repurposing tools: a survey.Systematic identification of latent disease-gene associations from PubMed articles.Molecular insights provide the critical path to disease mitigation.dbDEPC 3.0: the database of differentially expressed proteins in human cancer with multi-level annotation and drug indication.Cooperative Targets of Combined mTOR/HDAC Inhibition Promote MYC Degradation.Network-Based Analysis of Bortezomib Pharmacodynamic Heterogeneity in Multiple Myeloma Cells.Exploration of the Anti-Inflammatory Drug Space Through Network Pharmacology: Applications for Drug Repurposing.A systematic study of chemogenomics of carbohydrates.Network medicine: finding the links to personalized therapy.Finding melanoma drugs through a probabilistic knowledge graphMolecular Modeling for Protein Aggregation and FormulationCognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds
P2860
Q26823685-1B85A701-5996-4843-AD89-E9D8C210C3CAQ26829081-CFC9DF4A-CE04-420C-8651-9B95BFF7F1BAQ27024122-D2637069-B354-4CAF-9F4E-150DE9FF539EQ28076891-BB451C75-AD17-465D-9DF0-264B319A1317Q28545126-1650B41A-26A4-4723-84B5-56715D6DFF13Q28552140-2611CB03-C4ED-4D0C-86A5-FD3BF4E26B34Q28649771-35E230FE-4BEE-4481-8134-0EDEE54DCE85Q28650510-1F4B8177-7F89-4918-8A84-3DB27DB62E5CQ30354454-81DA5237-0285-463B-8FA8-EE936A2A6B57Q31074800-37E28499-3BDE-4AE0-A1E1-4CADE29CEA1CQ35118812-27198B20-F226-4FFA-B4FE-B159459E860EQ35332572-8377B295-3F67-43AC-BB0E-3120ED284C5EQ35962054-79BF492E-73C3-4E2B-931A-FA1A4640662DQ35964445-5870A8FE-2C80-418D-85D1-075DD4BB431CQ36030687-94940EE1-FB99-4493-8207-A25594BE0C93Q37029832-6D1405E5-3F6F-4C72-895D-F709132C0815Q38245231-0E37B6DD-AB6D-4F11-A30A-C60C08D8DD11Q38558090-E8502520-D800-4E80-B8BA-4DC81C02EDEFQ38686574-01ED37CC-64DA-4221-8A8A-887365B382BEQ38854124-CE807D7C-C666-4C80-85CC-A950F810524AQ39472758-753813F0-6AD2-4FFE-9247-F46AC241695EQ46261267-BEFE9D5E-7DC5-4F75-8402-4FDD5C7CB7A1Q47226889-78F85E26-0417-4A8B-B32B-5078B476FB6BQ47801769-F32A7E98-21ED-4CD1-A2C3-FC93BCA8668CQ48158859-AE685ABD-758C-4FB5-A329-F0DB659F45F1Q48384103-46D25528-2BDF-4A2B-B20B-F657206BC085Q50323444-921CE08B-19D1-41F9-A006-42FD5C8FF7CCQ50640068-B31095D3-A1A0-480E-A473-411C78BDA67EQ52597827-96A8A4FB-3E56-4BA4-A9FB-519B4E8712ADQ52653142-579C2CC9-E942-4966-BEF0-513CCC23CBA0Q53631411-74C6BBB8-91F1-4670-8F4E-3C3E9871C1DDQ54587200-FD337CE4-2415-4946-B5A3-071A54FB810AQ56160871-6F5A6D0C-B670-4CDD-B0B1-A9BC35AC5E5BQ57341107-16E22B2A-DF90-42E1-8D03-396A6D1CEEC7Q58764243-FB6687B5-84E8-48A3-AD60-921E6A9695CA
P2860
Network-based approaches in drug discovery and early development
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Network-based approaches in drug discovery and early development
@ast
Network-based approaches in drug discovery and early development
@en
Network-based approaches in drug discovery and early development
@nl
type
label
Network-based approaches in drug discovery and early development
@ast
Network-based approaches in drug discovery and early development
@en
Network-based approaches in drug discovery and early development
@nl
prefLabel
Network-based approaches in drug discovery and early development
@ast
Network-based approaches in drug discovery and early development
@en
Network-based approaches in drug discovery and early development
@nl
P2093
P2860
P3181
P356
P1476
Network-based approaches in drug discovery and early development
@en
P2093
J M Harrold
M Ramanathan
P2860
P3181
P356
10.1038/CLPT.2013.176
P407
P577
2013-12-01T00:00:00Z